Clinical Scorecard: Can Regulated Labs Trust AI?

At a Glance

Key Highlights

• Regulatory expectations are evolving to accommodate digital tools in laboratories.
• AI and machine learning are becoming integral to laboratory workflows.
• Data integrity standards have increased, requiring compliance with ALCOA++ principles.
• Automated systems reduce human error and improve operational efficiency.
• Human oversight remains critical in AI-driven processes.

Guideline-Based Recommendations

Diagnosis

• Regularly assess the accuracy and reliability of AI models.

Management

• Implement compliance by design using modern digital tools.

Monitoring & Follow-up

• Continuously monitor AI inputs and outputs for integrity.

Risks

• Ensure human-in-the-loop workflows for AI outputs.

Patient & Prescribing Data

Patients affected by pharmaceuticals developed in AI-enabled labs

AI tools can expedite the development of safe and effective pharmaceuticals.

Clinical Best Practices

• Embed compliance controls within digital workflows.
• Utilize electronic signatures and access rights for data integrity.
• Regularly validate and maintain digital tools to ensure compliance.

References

• FDA 21 CFR Part 11 Regulations
• European Union AI Act